The validity of the Rx-Risk comorbidity index using medicines mapped to the anatomical therapeutic chemical (ATC) classification system NL Pratt, M Kerr, JD Barratt, A Kemp-Casey, LMK Ellett, E Ramsay, ... BMJ open 8 (4), e021122, 2018 | 223 | 2018 |
Collaborative medication management services: improving patient care AL Gilbert, EE Roughead, K Mott, JD Barratt, J Beilby Medical Journal of Australia 177 (4), 189-192, 2002 | 206 | 2002 |
The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study EE Roughead, JD Barratt, E Ramsay, N Pratt, P Ryan, R Peck, G Killer, ... Circulation: Heart Failure 2 (5), 424-428, 2009 | 177 | 2009 |
Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia LM Kalisch Ellett, NL Pratt, EN Ramsay, JD Barratt, EE Roughead Journal of the American Geriatrics Society 62 (10), 1916-1922, 2014 | 142 | 2014 |
Medication‐related problems commonly occurring in an Australian community setting EE Roughead, JD Barratt, AL Gilbert Pharmacoepidemiology and drug safety 13 (2), 83-87, 2004 | 118 | 2004 |
Validity of medication‐based co‐morbidity indices in the Australian elderly population A Vitry, SA Wong, EE Roughead, E Ramsay, J Barratt Australian and New Zealand journal of public health 33 (2), 126-130, 2009 | 116 | 2009 |
Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting CY Lu, J Barratt, A Vitry, E Roughead Journal of clinical epidemiology 64 (2), 223-228, 2011 | 97 | 2011 |
Prevalence of potentially hazardous drug interactions amongst Australian veterans EE Roughead, LM Kalisch, JD Barratt, AL Gilbert British journal of clinical pharmacology 70 (2), 252-257, 2010 | 90 | 2010 |
Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans EE Roughead, JD Barratt, E Ramsay, N Pratt, P Ryan, R Peck, G Killer, ... Journal of clinical pharmacy and therapeutics 36 (1), 27-32, 2011 | 89 | 2011 |
Prevalence of preventable medication-related hospitalizations in Australia: an opportunity to reduce harm LM Kalisch, GE Caughey, JD Barratt, EN Ramsay, G Killer, AL Gilbert, ... International Journal for Quality in Health Care 24 (3), 239-249, 2012 | 88 | 2012 |
Association between use of multiple psychoactive medicines and hospitalization for falls: retrospective analysis of a large healthcare claim database NL Pratt, EN Ramsay, LM Kalisch Ellett, TA Nguyen, JD Barratt, ... Drug safety 37, 529-535, 2014 | 59 | 2014 |
Bridging evidence-practice gaps: improving use of medicines in elderly Australian veterans EE Roughead, LM Kalisch Ellett, EN Ramsay, NL Pratt, JD Barratt, ... BMC health services research 13, 1-14, 2013 | 45 | 2013 |
Use of proton pump inhibitors among older Australians: national quality improvement programmes have led to sustained practice change NL Pratt, LM Kalisch Ellett, JK Sluggett, SV Gadzhanova, EN Ramsay, ... International Journal for Quality in Health Care 29 (1), 75-82, 2017 | 33 | 2017 |
Understanding 30‐day re‐admission after hospitalisation of older patients for diabetes: identifying those at greatest risk GE Caughey, NL Pratt, JD Barratt, S Shakib, AR Kemp‐Casey, ... Medical Journal of Australia 206 (4), 170-175, 2017 | 31 | 2017 |
Risk of medication‐associated initiation of oxybutynin in elderly men and women LM Kalisch Ellett, NL Pratt, JD Barratt, D Rowett, EE Roughead Journal of the American Geriatrics Society 62 (4), 690-695, 2014 | 30 | 2014 |
An international comparison of spontaneous adverse event reports and potentially inappropriate medicine use associated with dabigatran CJ McDonald, LM Kalisch Ellett, JD Barratt, GE Caughey Pharmacoepidemiology and drug safety 24 (4), 399-405, 2015 | 29 | 2015 |
Posttraumatic stress disorder, antipsychotic use and risk of dementia in veterans EE Roughead, NL Pratt, LM Kalisch Ellett, EN Ramsay, JD Barratt, ... Journal of the American Geriatrics Society 65 (7), 1521-1526, 2017 | 23 | 2017 |
A cross-country comparison of rivaroxaban spontaneous adverse event reports and concomitant medicine use with the potential to increase the risk of harm CJ McDonald, LM Kalisch Ellett, JD Barratt, GE Caughey Drug safety 37, 1029-1035, 2014 | 20 | 2014 |
Medication use and potentially high‐risk prescribing in older patients hospitalized for diabetes: a missed opportunity to improve care? GE Caughey, JD Barratt, S Shakib, A Kemp‐Casey, EE Roughead Diabetic Medicine 34 (3), 432-439, 2017 | 19 | 2017 |
Medication adherence, first episode duration, overall duration and time without therapy: the example of bisphosphonates EE Roughead, E Ramsay, K Priess, J Barratt, P Ryan, AL Gilbert Pharmacoepidemiology and drug safety 18 (1), 69-75, 2009 | 18 | 2009 |